Aurum Biosciences is delighted to announce that Elaine Ferguson has joined us as our Chief Financial Officer

Elaine Ferguson CA who has extensive experience of managing and financing SMEs has joined Aurum Biosciences as our Chief Financial Officer.

Following an early career with Ernst and Young, Elaine has ten years’ experience in the life sciences industry, and has recently been part of an executive team who achieved a successful trade sale of Biopta to a global Japanese company.  Elaine has led fund raising into high growth companies and has incorporated and traded a US subsidiary company.

Elaine’s appointment further strengthens our existing management team, who in 2015 completed an initial $4.5m dollars investment to take our lead ABL-101 product into a clinical trial in stroke patients.